The role of CD40 and CD154/CD40L in dendritic cells

Seminars in Immunology

Volumn 21, Issue 5, 2009, Pages 265-272

  Ma, Daphne Y ^a   Clark, Edward A ^a  

^a Department of Immunology ^*  (United States)

Author keywords

CD154; CD40; CD40L; Dendritic cells

Indexed keywords

B CELL ACTIVATING FACTOR; B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE PIM 1; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; B LYMPHOCYTE; BACTERIAL IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST PATHOGEN INTERACTION; HUMAN; HYPER IGM SYNDROME; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS IMMUNITY;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 70349136587     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2009.05.010     Document Type: Review

References (129)

1. Ledbetter J.A., Shu G., Gallagher M., and Clark E.A. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J Immunol 138 (1987) 788-794
2. Stamenkovic I., Clark E.A., and Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8 (1989) 1403-1410
3. Torres R.M., and Clark E.A. Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J Immunol 148 (1992) 620-626
4. Clark E.A. CD40: a cytokine receptor in search of a ligand. Tissue Antigens 36 (1990) 33-36
5. Hart D.N., and McKenzie J.L. Isolation and characterization of human tonsil dendritic cells. J Exp Med 168 (1988) 157-170
6. Romani N., Lenz A., Glassel H., Stossel H., Stanzl U., Majdic O., et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 93 (1989) 600-609
7. Harnett M.M. CD40: a growing cytoplasmic tale. Sci STKE 2004 (2004) pe25
8. Clark E.A., and Ledbetter J.A. How B and T cells talk to each other. Nature 367 (1994) 425-428
9. Liu Y.J., Joshua D.E., Williams G.T., Smith C.A., Gordon J., and MacLennan I.C. Mechanism of antigen-driven selection in germinal centres. Nature 342 (1989) 929-931
10. van Kooten C., and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67 (2000) 2-17
11. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (1993) 990-993
12. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 (1993) 291-300
13. Brown M.P., Topham D.J., Sangster M.Y., Zhao J., Flynn K.J., Surman S.L., et al. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 4 (1998) 1253-1260
14. Conley M.E., Dobbs A.K., Farmer D.M., Kilic S., Paris K., Grigoriadou S., et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 27 (2009) 199-227
15. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541-543
16. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 539-541
17. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180 (1994) 1263-1272
18. Pinchuk L.M., Polacino P.S., Agy M.B., Klaus S.J., and Clark E.A. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1 (1994) 317-325
19. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179 (1994) 1109-1118
20. Hess S., and Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J Exp Med 183 (1996) 159-167
21. Galy A.H., and Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149 (1992) 775-782
22. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184 (1996) 747-752
23. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., and Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155 (1995) 4917-4925
24. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu Rev Immunol 12 (1994) 881-922
25. Pinchuk L.M., Klaus S.J., Magaletti D.M., Pinchuk G.V., Norsen J.P., and Clark E.A. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 157 (1996) 4363-4370
26. Salgado C.G., Nakamura K., Sugaya M., Tada Y., Asahina A., Koyama Y., et al. Functional CD40 ligand is expressed on epidermal Langerhans cells. J Leukoc Biol 66 (1999) 281-285
27. Masten B.J., Yates J.L., Pollard Koga A.M., and Lipscomb M.F. Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, CD54, and CD40L. Am J Respir Cell Mol Biol 16 (1997) 335-342
28. Kuwajima S., Sato T., Ishida K., Tada H., Tezuka H., and Ohteki T. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol 7 (2006) 740-746
29. Johnson S., Zhan Y., Sutherland R.M., Mount A.M., Bedoui S., Brady J.L., et al. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 30 (2009) 218-227
30. Grammer A.C., McFarland R.D., Heaney J., Darnell B.F., and Lipsky P.E. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol 163 (1999) 4150-4159
31. Lipsky P.E., Attrep J.F., Grammer A.C., McIlraith M.J., and Nishioka Y. Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function. Ann NY Acad Sci 815 (1997) 372-383
32. Wykes M., Poudrier J., Lindstedt R., and Gray D. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells. Eur J Immunol 28 (1998) 548-559
33. O'Sullivan B., and Thomas R. Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr Opin Hematol 10 (2003) 272-278
34. Williamson E., Bilsborough J.M., and Viney J.L. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. J Immunol 169 (2002) 3606-3612
35. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
36. Brodeur S.R., Angelini F., Bacharier L.B., Blom A.M., Mizoguchi E., Fujiwara H., et al. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18 (2003) 837-848
37. Clark E.A., and Craxton A. A CD40 bridge between innate and adaptive immunity. Immunity 18 (2003) 724-725
38. Kawai T., and Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13 (2007) 460-469
39. Ip W.K., and Lau Y.L. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J Immunol 173 (2004) 189-196
40. Bishop G.A., and Hostager B.S. Signaling by CD40 and its mimics in B cell activation. Immunol Res 24 (2001) 97-109
41. Yasui T., Muraoka M., Takaoka-Shichijo Y., Ishida I., Takegahara N., Uchida J., et al. Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals. Int Immunol 14 (2002) 319-329
42. Rolink A.G., Andersson J., and Melchers F. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol 28 (1998) 3738-3748
43. Sater R.A., Sandel P.C., and Monroe J.G. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 10 (1998) 1673-1682
44. Aicher A., Shu G.L., Magaletti D., Mulvania T., Pezzutto A., Craxton A., et al. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J Immunol 163 (1999) 5786-5795
45. Craxton A., Shu G., Graves J.D., and Saklatvala J. Krebs EG, and Clark EA. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J Immunol 161 (1998) 3225-3236
46. Dadgostar H., Zarnegar B., Hoffmann A., Qin X.F., Truong U., Rao G., et al. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci U S A 99 (2002) 1497-1502
47. Zhu N., Ramirez L.M., Lee R.L., Magnuson N.S., Bishop G.A., and Gold M.R. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J Immunol 168 (2002) 744-754
48. Kobayashi T., Walsh M.C., and Choi Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect 6 (2004) 1333-1338
49. Vidalain P.O., Azocar O., Servet-Delprat C., Rabourdin-Combe C., Gerlier D., and Manie S. CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J 19 (2000) 3304-3313
50. Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T., Suzuki K., et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271 (1996) 28745-28748
51. Pullen S.S., Dang T.T., Crute J.J., and Kehry M.R. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 274 (1999) 14246-14254
52. Yanagawa Y., and Onoe K. Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells. Immunology 117 (2006) 526-535
53. Kobayashi T., Walsh P.T., Walsh M.C., Speirs K.M., Chiffoleau E., King C.G., et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19 (2003) 353-363
54. Lind E.F., Ahonen C.L., Wasiuk A., Kosaka Y., Becher B., Bennett K.A., et al. Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens. J Immunol 181 (2008) 354-363
55. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170 (2003) 4465-4474
56. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 (1997) 175-179
57. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186 (1997) 2075-2080
58. Bharti A.C., and Aggarwal B.B. Ranking the role of RANK ligand in apoptosis. Apoptosis 9 (2004) 677-690
59. Yun T.J., Chaudhary P.M., Shu G.L., Frazer J.K., Ewings M.K., Schwartz S.M., et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 161 (1998) 6113-6121
60. Leibbrandt A., and Penninger J.M. RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci 1143 (2008) 123-150
61. Josien R., Wong B.R., Li H.L., Steinman R.M., and Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162 (1999) 2562-2568
62. Galibert L., Tometsko M.E., Anderson D.M., Cosman D., and Dougall W.C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem 273 (1998) 34120-34127
63. Yu Q., Gu J.X., Kovacs C., Freedman J., Thomas E.K., and Ostrowski M.A. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. J Immunol 170 (2003) 1797-1805
64. Yurkovetsky Z.R., Shurin G.V., Barry D.A., and Schuh A.C. Shurin MR, and Robbins PD. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells. J Gene Med 8 (2006) 129-137
65. Miyahira Y., Akiba H., Katae M., Kubota K., Kobayashi S., Takeuchi T., et al. Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination. J Immunol 171 (2003) 6344-6348
66. Hou W.S., and Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 5 (2004) 583-589
67. Quezada S.A., Jarvinen L.Z., Lind E.F., and Noelle R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22 (2004) 307-328
68. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272 (1997) 25190-25194
69. Chen A., Xu H., Choi Y., Wang B., and Zheng G. TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells. Cell Immunol 231 (2004) 40-48
70. Bjorck P., Banchereau J., and Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 9 (1997) 365-372
71. Ouaaz F., Arron J., Zheng Y., Choi Y., and Beg A.A. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16 (2002) 257-270
72. Cremer I., Dieu-Nosjean M.C., Marechal S., Dezutter-Dambuyant C., Goddard S., Adams D., et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 100 (2002) 3646-3655
73. Naik S.H. Demystifying the development of dendritic cell subtypes, a little. Immunol Cell Biol 86 (2008) 439-452
74. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 (2002) 151-161
75. Hellman P., and Eriksson H. Early activation markers of human peripheral dendritic cells. Hum Immunol 68 (2007) 324-333
76. Della Bella S., Giannelli S., Taddeo A., Presicce P., and Villa M.L. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods 339 (2008) 153-164
77. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 195 (2002) 1507-1512
78. Liang H., Russell R.S., Yonkers N.L., McDonald D., Rodriguez B., Harding C.V., et al. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 83 (2009) 5693-5707
79. Veckman V., and Julkunen I. Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells. J Leukoc Biol 83 (2008) 296-304
80. Vandenabeele S., Hochrein H., Mavaddat N., Winkel K., and Shortman K. Human thymus contains 2 distinct dendritic cell populations. Blood 97 (2001) 1733-1741
81. Martin P., del Hoyo G.M., Anjuere F., Ruiz S.R., Arias C.F., Marin A.R., et al. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4 (low) lymphoid-committed precursors. Blood 96 (2000) 2511-2519
82. Jomantaite I., Dikopoulos N., Kroger A., Leithauser F., Hauser H., Schirmbeck R., et al. Hepatic dendritic cell subsets in the mouse. Eur J Immunol 34 (2004) 355-365
83. O'Connell P.J., Morelli A.E., Logar A.J., and Thomson A.W. Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells. J Immunol 165 (2000) 795-803
84. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 6 (2006) 476-483
85. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
86. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci 987 (2003) 258-261
87. Delgado M., Gonzalez-Rey E., and Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 175 (2005) 7311-7324
88. Sato K., Yamashita N., Baba M., and Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18 (2003) 367-379
89. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
90. Coquerelle C., and Moser M. Are dendritic cells central to regulatory T cell function?. Immunol Lett 119 (2008) 12-16
91. Wong K.A., and Rodriguez A. Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. J Immunol 180 (2008) 716-726
92. Poncini C.V., Alba Soto C.D., Batalla E., Solana M.E., and Gonzalez Cappa S.M. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect Immun 76 (2008) 2633-2641
93. + T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells. Int Immunol 16 (2004) 1037-1052
94. +CD25+Foxp3+ regulatory T cells. J Immunol 182 (2009) 2795-2807
95. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 (2005) 1219-1227
96. Hawiger D., Masilamani R.F., Bettelli E., Kuchroo V.K., and Nussenzweig M.C. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20 (2004) 695-705
97. Jaen O., Rulle S., Bessis N., Zago A., Boissier M.C., and Falgarone G. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Immunology 126 (2009) 35-44
98. + T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 177 (2006) 5868-5877
99. Mackey M.F., Gunn J.R., Maliszewsky C., Kikutani H., Noelle R.J., and Barth Jr. R.J. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161 (1998) 2094-2098
100. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
101. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273 (1996) 1864-1867
102. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63 (1998) 418-428
103. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184 (1996) 741-746
104. + T cells. J Immunol 154 (1995) 5071-5079
105. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1 (1994) 167-178
106. Castigli E., Alt F.W., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A 91 (1994) 12135-12139
107. Lu L., Li W., Fu F., Chambers F.G., Qian S., Fung J.J., et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64 (1997) 1808-1815
108. Shepherd D.M., and Kerkvliet N.I. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation. J Immunol 163 (1999) 2470-2477
109. + T cells. Proc Natl Acad Sci U S A 106 (2009) 876-881
110. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
111. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7 (2006) 1151-1156
112. Bergtold A., Desai D.D., Gavhane A., and Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23 (2005) 503-514
113. Qi H., Egen J.G., Huang A.Y., and Germain R.N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312 (2006) 1672-1676
114. Wykes M., and MacPherson G. Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 100 (2000) 1-3
115. Parker D.C. T cell-dependent B cell activation. Annu Rev Immunol 11 (1993) 331-360
116. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
117. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
118. Konrad A., Cong Y., Duck W., Borlaza R., and Elson C.O. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 130 (2006) 2050-2059
119. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448 (2007) 929-933
120. Craxton A., Magaletti D., Ryan E.J., and Clark E.A. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101 (2003) 4464-4471
121. Grewal I.S., Xu J., and Flavell R.A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378 (1995) 617-620
122. Renshaw B.R., Fanslow III W.C., Armitage R.J., Campbell K.A., Liggitt D., Wright B., et al. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 180 (1994) 1889-1900
123. van Essen D., Kikutani H., and Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378 (1995) 620-623
124. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J.J., Waldschmidt T.J., et al. Mice deficient for the CD40 ligand. Immunity 1 (1994) 423-431
125. Borrow P., Tishon A., Lee S., Xu J., Grewal I.S., Oldstone M.B., et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183 (1996) 2129-2142
126. Clarke S.R. The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity. J Leukoc Biol 67 (2000) 607-614
127. Kelleher M., and Beverley P.C. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential. J Immunol 167 (2001) 6247-6255
128. + T cell clones. Semin Immunol 5 (1993) 421-430
129. Chino T, Draves KE, Clark EA. Regulation of dendritic cell survival and cytokine production by osteoprotegerin. J Leukoc Biol 2009; in press.